4475 Wayburne Drive
Burnaby, BC V5G 4X4
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 11
|Mr. Benjamin Lightburn||Co-Founder, CEO & Chairman||129.26k||N/A||1987|
|Mr. Warren Duncan CPA||Chief Financial Officer||110.79k||N/A||1991|
|Mr. Jon Conlin||Corp. Sec. & Director||N/A||N/A||1986|
|Ms. Lisa Ranken||Chief Operating Officer||N/A||N/A||1984|
|Mr. Ryan Moss||Chief Science Officer||N/A||N/A||N/A|
|Ms. Anna Cordon||Director of Communications||N/A||N/A||N/A|
|Mr. Jeff Fellows||Head of Regulatory||N/A||N/A||N/A|
Filament Health Corp. operates as a clinical-stage natural psychedelic drug development company. The company propagates psychedelic plants and fungi; conducts genetic research; develops manufacturing technology; generates intellectual property; conducts in-house trials; and distributes drug candidates to drug developers, researchers, and other licensed parties. Filament Health Corp. is headquartered in Burnaby, Canada.
Filament Health Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.